PEDIATRIC GRAND ROUNDS
Washington University School of Medicine
& St. Louis Children’s Hospital
9:15 - 10:15 am
Clopton Auditorium
January 2014
January 3
No Grand Rounds
January 10
“Implementation Strategies For Pediatric Neurocritical
Care: Reliable Penetration Of Best Practice Into The ICU
Environment”
Jose Pineda, MD
Associate Professor of Pediatrics and Neurology
Division of Pediatric Critical Care
Washington University School of Medicine
January 17
“Genetic Variation among Infants with Respiratory
Distress Syndrome”
Jennifer Wambach, MD
Assistant Professor of Pediatrics
Division of Newborn Medicine
Washington University School of Medicine
January 24
“Pathophysiologic Angiogenesis: The Least Common
Denominator in Chronic Transplant Rejection.”
Michael Seifert, MD
Assistant Professor of Pediatrics
Division of Pediatric Nephrology
Washington University School of Medicine
January 31
“From Animal Models to Clinical Trials: Developing Novel
Therapies for Patients with Neurofibromatosis Type I”
David A. Ingram, Jr., M.D.
Hugh McK Landon Professor of Pediatrics, and of
Biochemistry and Molecular Biology
Director, Section of Neonatal-Perinatal Medicine
Indiana University School of Medicine
Washington University is accredited by the Accreditation Council of Continuing Medical Education to sponsor continuing medical education for
physicians.WashingtonUniversitydesignates CLIN CASE CONF and PED GRAND ROUNDS for a maximum of 1.25 hours each and EARLY BIRD ROUNDS for 1.0 hour in
Category 1 credit toward the AMA Physicians’ Recognition Award. Physicians should claim only those hours of credit that they actually spend in the education activity. This
activity is being sponsored by Washington Uiversity School of Medicine, Continuing Medical Education.DISCLOSURE POLICY
It is the policy of Washington University School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational
activities. All faculty participating in this activity are expected to disclose to the audience any significant financial interest or other relationship he/she has with the
manufacturer(s) of any commercial product(s) discussed in an educational presentation